Back

Relationship of inflammatory factors with migraine in patients with patent foramen ovale undergoing percutaneous closure

30 August 2024 (10:00 - 10:50)
Organised by: Logo
Congress Presentation Part of: Patent foramen ovale and left atrial appendage closure: what's new? Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Kyriakos Dimitriadis

Hippokration General Hospital, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
Incidence, determinants, and impact of in-hospital complications during percutaneous patent foramen ovale closure
Doctor A. SOUQUET (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Evaluation of efficacy and safety of simplified procedure for the percutaneous closure of patent foramen ovale: the Ile De France Foramen Ovale Permeable(IDFFOP) prospective, multicenter cohort study
Doctor P. Kamtchueng (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation: an updated systematic review and meta-analysis
Miss N. Andrade (Salvador, BR)
Abstract Slides Video
Presentation thumbnail
A novel bionic constructional left atrial appendage occlude device: the result of preclinical experiment and first-in-human study
Doctor D. Lin (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Anatomical classification of patent foramen ovale before percutaneous closure
Doctor G. Chevrot (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Patent foramen ovale and left atrial appendage closure: what's new?

The Event

Event poster

ESC Congress 2024

30 August 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Shunt related platelet activation in patients with patent foramen ovale
thumbnail
Congress Presentation
Reporting quality of randomized controlled trials of percutaneous patent foramen ovale closure for the treatment of migraine based on the CONSORT statement
thumbnail
Congress Presentation
Incidence, determinants, and impact of in-hospital complications during percutaneous patent foramen ovale closure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources